Watch a Friday, December 17 Broad community update in which Broad associate member & physician-scientist @roby_bhatt discusses the latest science around the COVID-19 Omicron variant, boosters, and more. https://t.co/janDfxwTzC
Progress in hepatitis C virus management in chronic kidney... : Current Opinion in Nephrology and Hypertension https://t.co/O3mdaU9RTz @Gordon7Craig @acbucay@bu_bmc_renal
I feel like we didn’t focus enough on the fact that someone in the Trump campaign meant to schedule the “four seasons hotel” but definitely accidentally scheduled this “four seasons landscaping” store and they had to follow through with it. Veep was not this good.
Not only is there no evidence that homeopathy works. It CANNOT work unless “water has a memory”. If they could show that they’d win the Nobel Prize for Physics as well as Medicine. Needless to say, they can’t. Homeopathy is fraud, pure & simple
https://t.co/Iw2JTUIKj3
@rafavaldeznefro @NephroGuy @gpaymd@DrJ_Fonseca Que hacen ahora con los diabeticos de larga evolucion con evidencia de microangiopatia? Inician con estudios no invasivos?
@rafavaldeznefro @NephroGuy @DrJ_Fonseca Individualizar es exacto lo que estoy proponiendo. A pacientes de alto riesgo no se debe de hacer prueba de esfuerzo (eco dobuta o sestamibi) e ir directo a cateterismo. Si es mas caro, pero necesario
@rafavaldeznefro @NephroGuy @DrJ_Fonseca En pacientes con alto riesgo cardiovascular, la probabilidad postprueba de un sestamibi negativo es muy baja. Mi propuesta es que en estos pacientes NO se hagan sestamibis (y es lo que se hace en muchos otros centros) por la tasa de falsos negativos
@NephroGuy @DrJ_Fonseca Con la evidencia que hay del score de calcio y tomografia coronaria, no creo que sean estudios que se deban de usar para evaluacion para trasplante renal. En esta revision que publicamos hace poco cito todos los estudios al respecto https://t.co/gbuiURapJE
@NephroGuy @DrJ_Fonseca Lo que se hace en otros centros es no realizar la coronariografia hasta que esten suficientemente altos en la lista de espera. Especificamente para disminuir costos. Pero que tan frecuente se deben repetir los estudios es muy debatible por falta de evidencia
@galindozip@NefroINCMNSZ@EdoardoMelilli@bthomas215@AdnanSharif1979 Here are some (not all) review papers on this very controversial topic. Our algorithm might not be perfect, but it is our conclusion of the data available https://t.co/bZy5kdRJre https://t.co/qJ3Ku5O9CF https://t.co/60EQMooldv
@BCBSMAservice how can I get my 1099-HC if I am no longer insured by BCBS and I changed my address? where can I contact you to get information about this issue? what is the member services phone number?
% satisfied with the way democracy is working in their country
India, Sweden, Tanzania 79% (highest)
Germany 73%
Canada 70%
Russia 59%
UK 52%
Japan 50%
US 46%
France 34%
S. Korea 30%
Brazil 28%
Spain 25%
Mexico 6% (lowest)
(Pew)